Current Environment: Production

Medical Services

Programs & Services

Education

Undergraduate School

St Xavier’s College

2000, Mumbai, India

Graduate School

University of Mumbai College of Home Science

2002, Mumbai, India

Graduate School

PhD, Clinical Psychology

Illinois Institute of Technology

2008, Chicago, IL

Internship

Clinical Psychology

Louisiana State University Health Sciences Center

2008, New Orleans, LA

Fellowship

Psychology

Boston Children's Hospital

2010, Boston, MA

Publications

  1. Parental stress and family quality of life in families of individuals living with Angelman syndrome. medRxiv. 2025 May 08. View Abstract

  2. Developing Meaningful Score Differences for the Bayley-4 and Vineland-3 in Angelman Syndrome using a Delphi Panel. medRxiv. 2025 Apr 07. View Abstract

  3. Foetal cortical expansion is associated with neurodevelopmental outcome at 2-years in congenital heart disease: a longitudinal follow-up study. EBioMedicine. 2025 Apr; 114:105679. View Abstract

  4. Retrospective analysis of early neurodevelopmental outcomes after esophageal atresia repair at a single institution: short-gap vs. long-gap defect. Front Pediatr. 2025; 13:1527880. View Abstract

  5. Developmental milestones and daily living skills in individuals with Angelman syndrome. J Neurodev Disord. 2024 Jun 15; 16(1):32. View Abstract

  6. Factors Associated With Attendance for Cardiac Neurodevelopmental Evaluation. Pediatrics. 2023 09 01; 152(3). View Abstract

  7. Inpatient Screening for Early Identification of Developmental Risk in Infants with Congenital Heart Defects. J Pediatr. 2023 12; 263:113687. View Abstract

  8. Adaptive Skills of Individuals with Angelman Syndrome Assessed Using the Vineland Adaptive Behavior Scales, 2nd Edition. J Autism Dev Disord. 2024 Oct; 54(10):3863-3887. View Abstract

  9. Impact of Residual Lesion Severity on Neurodevelopmental Outcomes Following Congenital Heart Surgery in Infancy and Childhood. Pediatr Cardiol. 2024 Dec; 45(8):1676-1691. View Abstract

  10. Enabling endpoint development for interventional clinical trials in individuals with Angelman syndrome: a prospective, longitudinal, observational clinical study (FREESIAS). J Neurodev Disord. 2023 07 26; 15(1):22. View Abstract

  11. Development of the data registry for the Cardiac Neurodevelopmental Outcome Collaborative. Cardiol Young. 2024 Jan; 34(1):79-85. View Abstract

  12. Preterm congenital heart disease and neurodevelopment: the importance of looking beyond the initial hospitalization. J Perinatol. 2023 07; 43(7):958-962. View Abstract

  13. Impact of tight glycemic control and hypoglycemia after pediatric cardiac surgery on neurodevelopmental outcomes at three years of age: Findings from a randomized clinical trial. BMC Pediatr. 2022 09 07; 22(1):531. View Abstract

  14. Sleep Patterns in Young Children with Congenital Heart Disease. J Pediatr. 2023 01; 252:198-203.e2. View Abstract

  15. Integrating Telehealth Into Neurodevelopmental Assessment: A Model From the Cardiac Neurodevelopmental Outcome Collaborative. J Pediatr Psychol. 2022 06 07; 47(6):707-713. View Abstract

  16. Telehealth services for cardiac neurodevelopmental care during the COVID-19 pandemic: a site survey from the Cardiac Neurodevelopmental Outcome Collaborative. Cardiol Young. 2023 Feb; 33(2):280-287. View Abstract

  17. Methylation analysis and developmental profile of two individuals with Angelman syndrome due to mosaic imprinting defects. Eur J Med Genet. 2022 Apr; 65(4):104456. View Abstract

  18. A multidisciplinary approach and consensus statement to establish standards of care for Angelman syndrome. Mol Genet Genomic Med. 2022 03; 10(3):e1843. View Abstract

  19. Fetal Brain Volume Predicts Neurodevelopment in Congenital Heart Disease. Circulation. 2022 04 12; 145(15):1108-1119. View Abstract

  20. Anxiety in Angelman Syndrome. Am J Intellect Dev Disabil. 2022 01 01; 127(1):1-10. View Abstract

  21. Neurological features in infants with congenital heart disease. Dev Med Child Neurol. 2022 06; 64(6):762-770. View Abstract

  22. Characterisation of neurodevelopmental and psychological outcomes in CHD: a research agenda and recommendations from the cardiac neurodevelopmental outcome collaborative. Cardiol Young. 2021 Jun; 31(6):876-887. View Abstract

  23. Developmental Skills of Individuals with Angelman Syndrome Assessed Using the Bayley-III. J Autism Dev Disord. 2023 Feb; 53(2):720-737. View Abstract

  24. Neurodevelopmental evaluation strategies for children with congenital heart disease aged birth through 5 years: recommendations from the cardiac neurodevelopmental outcome collaborative. Cardiol Young. 2020 Nov; 30(11):1609-1622. View Abstract

  25. Comprehensive Assessment of Individuals With Significant Levels of Intellectual Disability: Challenges, Strategies, and Future Directions. Am J Intellect Dev Disabil. 2020 11 01; 125(6):434-448. View Abstract

  26. Variations in practice in cardiac neurodevelopmental follow-up programs. Cardiol Young. 2020 Nov; 30(11):1603-1608. View Abstract

  27. Angelman syndrome genotypes manifest varying degrees of clinical severity and developmental impairment. Mol Psychiatry. 2021 07; 26(7):3625-3633. View Abstract

  28. Neurodevelopmental profile of siblings with Angelman syndrome due to pathogenic UBE3A variants. J Intellect Disabil Res. 2020 03; 64(3):246-250. View Abstract

  29. Early Neurodevelopmental Outcomes in Children Supported with ECMO for Cardiac Indications. Pediatr Cardiol. 2019 Jun; 40(5):1072-1083. View Abstract

  30. Maladaptive behaviors in individuals with Angelman syndrome. Am J Med Genet A. 2019 06; 179(6):983-992. View Abstract

  31. Neurodevelopmental assessment of infants with congenital heart disease in the early postoperative period. Congenit Heart Dis. 2019 Mar; 14(2):236-245. View Abstract

  32. Two Angelman families with unusually advanced neurodevelopment carry a start codon variant in the most highly expressed UBE3A isoform. Am J Med Genet A. 2018 07; 176(7):1641-1647. View Abstract

  33. Everolimus for treatment of tuberous sclerosis complex-associated neuropsychiatric disorders. Ann Clin Transl Neurol. 2017 12; 4(12):877-887. View Abstract

  34. A randomized controlled trial of levodopa in patients with Angelman syndrome. Am J Med Genet A. 2018 05; 176(5):1099-1107. View Abstract

  35. Neurodevelopmental Outcome in Children after Fetal Cardiac Intervention for Aortic Stenosis with Evolving Hypoplastic Left Heart Syndrome. J Pediatr. 2017 05; 184:130-136.e4. View Abstract

  36. Effect of Adenotonsillectomy on Parent-Reported Sleepiness in Children with Obstructive Sleep Apnea. Sleep. 2016 Nov 01; 39(11):2005-2012. View Abstract

  37. Cognitive Effects of Adenotonsillectomy for Obstructive Sleep Apnea. Pediatrics. 2016 08; 138(2). View Abstract

  38. Neurocognitive Deficits in Adolescent Survivors of Neonatal Extracorporeal Membrane Oxygenation: The Evidence Unfolds. Crit Care Med. 2016 06; 44(6):1243-4. View Abstract

  39. Impact of Tight Glycemic Control on Neurodevelopmental Outcomes at 1 Year of Age for Children with Congenital Heart Disease: A Randomized Controlled Trial. J Pediatr. 2016 07; 174:193-198.e2. View Abstract

  40. Association between Technical Performance Scores and neurodevelopmental outcomes after congenital cardiac surgery. J Thorac Cardiovasc Surg. 2014 Jul; 148(1):232-237.e3. View Abstract
BESbswy